PIMA532963

IL18BP Monoclonal Antibody (7C6), Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIMA532963-Each-of-1 In Stock ₹ 50,596.50

PIMA532963 - Each of 1

₹ 50,596.50

In Stock

Quantity

1

Base Price: ₹ 50,596.50

GST (18%): ₹ 9,107.37

Total Price: ₹ 59,703.87

Antigen

IL18BP

Classification

Monoclonal

Concentration

1.0 mg/mL

Formulation

PBS with 50% glycerol and 0.02% sodium azide, pH 7.2

Gene Accession No.

O95998

Gene Symbols

IL18BP

Immunogen

Recombinant full length Human IL18BP.

Quantity

100 μL

Primary or Secondary

Primary

Target Species

Human

Product Type

Antibody

Isotype

IgG2b

Applications

Western Blot

Clone

7C6

Conjugate

Unconjugated

Gene

IL18BP

Gene Alias

Igifbp, Il18bp, IL-18BP, IL18BPa, interferon gamma inducing factor binding protein, interferon gamma-inducing factor-binding protein, interleukin 18 binding protein, interleukin-18 binding protein, interleukin-18-binding protein, MC51L-53L-54L homolog gene product, MC54L, Tadekinig-alfa

Host Species

Mouse

Purification Method

Antigen affinity chromatography

Regulatory Status

RUO

Gene ID (Entrez)

10068

Content And Storage

Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.

Form

Liquid

Related Products

Img

Thermo Scientific

PIMA532961

--

Img

Thermo Scientific

PIMA532892

--

Img

Thermo Scientific

PIMA532251

--

Img

Thermo Scientific

PIMA532309

--

Img

Thermo Scientific

PIMA532967

--

Img

Thermo Scientific

PIMA532931

--

Img

Thermo Scientific

PIMA532550

--

Img

Thermo Scientific

PIMA532965

--

Description

  • Interleukin-18 binding protein (IL-18BP) is a constitutively secreted glycoprotein that acts as a natural antagonist for interleukin-18 (IL-18) by preventing interaction between IL-18 and its receptors
  • Through this binding, IL-18BP neutralizes the proinflammatory role of IL-18 in cell-mediated immune responses, resulting in reduced IFN-gamma production by T helper type I cells and inhibition of allospecific cytotoxic T lymphocyte (CTL) activity through augmented natural killer (NK) cell cytotoxicity
  • As an inhibitor of IL-18 and an essential component of skin homeostasis, IL-18BP has been linked to a variety of diseases, including eczema, asthma, and the autoimmune condition, Crohn's disease
  • The upregulation of IL-18BP by keratinocytes expressing the human papillomavirus (HPV) E7 oncoprotein has been shown to decrease IL-18-induced IFN-gamma production and IL-18-mediated T cell activation
  • Elevated levels of IL-18 and IL-18BP, as well as proinflammatory cytokines IFN-gamma, TNF-alpha, IL-1beta and IL-8, have been linked to chronic inflammation and observed in macrophages (including Kupffer cells) isolated from lesions and intestinal tissues of Crohn's disease patients
  • As a member of the immunoglobulin-like class of receptors, IL-18BP contains a single immunoglobulin (Ig) domain; although two (b and d) of the four identified human isoforms (a-d) contain incomplete domains that greatly reduce their binding affinity.